Community Health Systems, Inc.
NYSE:CYHMedical - Care Facilities
+$0.05 today
- Market cap
- $262.31M
- Beta
- 1.86
- P/E (TTM)
- -4.6
- EPS (TTM)
- -$0.66
Volume 2.88M
Average 1.61M
CYH Sales of Investments
Cash received from selling or redeeming investments.
Community Health Systems, Inc.NYSE: CYH
Sales of Investments · Q1 FY2026 · quarter ended Mar 2026
Sales of investments growth accelerates
Q1 FY2026 sales of investments of $45M rose 95.7% year over year, ahead of the +59.3% change in trailing-twelve-month sales of investments. Sequentially, it rose 25.0% from the prior quarter. Over 3 fiscal years it compounded at +3.8% a year.
Context
- Sales of investments amounted to 1.0% of revenue in FY2025, up 0.4 pp from a year earlier.
- Sales of investments increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +95.7% holds above the trailing-twelve-month pace of +59.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 123M USD
- Year-over-year change
- +53.8%
- 4-year CAGR
- -12.7%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 123M | +53.8% |
| FY2024 | 2024-12-31 | 80M | -65.5% |
| FY2023 | 2023-12-31 | 232M | +110.9% |
| FY2022 | 2022-12-31 | 110M | -48.1% |
| FY2021 | 2021-12-31 | 212M | — |
Sales of Investments vs competitors
How CYH compares with its peers on the latest reported figures
- Peers report in different currencies, so sales of investments is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +59.3% is the 3rd highest of 6, against a peer median of -10.8%.
- Sales of investments amounts to 0.7% of revenue for CYH, versus a peer median of 0.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $286.12M USD | -10.8% | +33.3% | 324.2% | |
| LTM Mar 2026 | $145M USD | +59.3% | +3.8% | 0.7% | |
AUNAAuna S.A. | LTM Mar 2026 | PEN 81.8M PEN | +4974.7% | — | 1.8% |
| LTM Mar 2026 | $52.15M USD | +1420.4% | — | 21.9% | |
| LTM Apr 2026 | $18.1M USD | -78.7% | +219.8% | 2.1% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | — | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| Peer median (excluding CYH) | — | -10.8% | +126.6% | 0.9% | |
Competitors are the stored peer set for CYH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 230M | 46M | (133M) | (516M) | 676M |
| Depreciation & Amortization | 540M | 534M | 505M | 486M | 426M |
| Deferred Income Tax | 170M | 165M | 35M | (116M) | (243M) |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 11M |
| Change in Working Capital | (1.38B) | (479M) | (390M) | (9M) | 3M |
| Accounts Receivables | (136M) | 22M | (193M) | (66M) | 99M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 16M | (158M) | (50M) | 137M | (36M) |
| Other Working Capital | (1.26B) | (343M) | (147M) | (80M) | (60M) |
| Other Non-Cash Items | 305M | 34M | 193M | 635M | (330M) |
| Operating Cash Flow | (131M) | 300M | 210M | 480M | 543M |
| Capital Expenditures | (469M) | (415M) | (467M) | (360M) | (335M) |
| Acquisitions (Net) | 5M | 126M | 426M | 152M | 1.26B |
| Purchases of Investments | (291M) | (193M) | (213M) | (149M) | (139M) |
| Sales of Investments | 212M | 110M | 232M | 80M | 123M |
| Other Investing Activities | 0 | 121M | 0 | 0 | (62M) |
| Investing Cash Flow | (543M) | (251M) | (22M) | (277M) | 847M |
| Debt Repayment | (369M) | (305M) | (123M) | (48M) | (1B) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (5M) | (8M) | (4M) | (1M) | (2M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (121M) | (125M) | (141M) | (155M) | (165M) |
| Financing Cash Flow | (495M) | (438M) | (268M) | (204M) | (1.17B) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (1.17B) | (389M) | (80M) | (1M) | 223M |
| Free Cash Flow | (600M) | (115M) | (257M) | 120M | 208M |
Community Health Systems, Inc.
NYSE:CYH
Intrinsic Alpha fair value
Locked
Current Price
$1.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.